Francis Collins
Residents wearing face masks to help curb the spread of the coronavirus line up to receive the Sinopharm COVID-19 vaccine at the Central Business District in Beijing, Wednesday, June 2, 2021. (AP Photo/Andy Wong)
EXPLAINER: The US investigation into COVID-19 origins

By Christina Larson And Nomaan Merchant Jun. 09, 2021 12:15 AM EDT

FILE - In this Jan. 27, 2021, image from video, Andy Slavitt, senior adviser to the White House COVID-19 Response Team, speaks during a White House briefing on the Biden administration's response to the COVID-19 pandemic in Washington. Slavitt, a top White House aide is making his pitch for young people to get vaccinated personal by sharing the struggles his own son has dealt with since contracting COVID-19 last fall. (White House via AP)
Biden adviser makes personal appeal to young to get shots

By Zeke Miller May. 18, 2021 11:27 AM EDT

Priscilla Medina stands with her husband, Jason Sanchez, and her son in the Rego Park neighborhood of Queens in New York on Wednesday, April 7, 2021. If Medina had gotten COVID-19 a year earlier, she would have had no treatments proven safe and effective to try. But when the 30-year-old nurse arrived at a Long Island hospital in March 2021, so short of breath she could barely talk, doctors knew just what to do. They quickly arranged for her to get a novel drug that supplies virus-blocking antibodies, and “by the next day I was able to get up and move around,” she said. After two days, “I really started turning the corner. I was showering, eating, playing with my son.” (AP Photo/Marshall Ritzel)
COVID treatment has improved, but many wish for an easy pill

By Marilynn Marchione Apr. 26, 2021 10:24 AM EDT

Rev. Patricia Hailes Fears, pastor of the Fellowship Baptist Church in Washington, is administered with the Johnson & Johnson COVID-19 vaccine during a gathering of a group of interfaith clergy members, community leaders and officials at the Washington National Cathedral, to encourage faith communities to get the COVID-19 vaccine, Tuesday, March 16, 2021, in Washington. (AP Photo/Manuel Balce Ceneta)
Faith leaders get COVID-19 shot to curb vaccine reluctance

Manuel Balce Ceneta Mar. 16, 2021 08:40 PM EDT

Karla Jefferies is shown in her kitchen in Detroit, Friday, March 5, 2021. As an African-American woman with diabetes and high blood pressure, she was at high risk for a bad outcome from COVID-19 and knows she’s lucky her initial illness wasn’t more serious. But her persistent symptoms and home confinement got her down and depression set in. (AP Photo/Paul Sancya)
Survivors struggle as scientists race to solve COVID mystery

By Lindsey Tanner Mar. 14, 2021 01:32 PM EDT

FILE - This July 2020 photo provided by Johnson & Johnson shows a vial of the COVID-19 vaccine in Belgium. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two.(Johnson & Johnson via AP, File)
J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine

By Lauran Neergaard And Matthew Perrone Feb. 27, 2021 06:52 PM EST

President-elect Joe Biden's nominee to co-chair the President's Council of Advisors on Science and Technology Maria Zuber speaks during an event at The Queen theater, Saturday, Jan. 16, 2021, in Wilmington, Del. (AP Photo/Matt Slocum)
Biden says his advisers will lead with 'science and truth'

By Bill Barrow And Seth Borenstein Jan. 16, 2021 04:49 PM EST

Pharmacist Nadine M. Mackey, right, and registered nurse Gloria Campbell, center, react after Campbell received a COVID-19 vaccination at PowerBack Rehabilitation, in Phoenixville, Pa., Monday, Dec. 28, 2020. (Jose F. Moreno/The Philadelphia Inquirer via AP)
More COVID-19 vaccines in the pipeline as US effort ramps up

By Lauran Neergaard Dec. 28, 2020 04:02 PM EST

People check in at a food bank held at Los Angeles Boys & Girls Club in the Lincoln Heights neighborhood of Los Angeles, Thursday, Dec. 17, 2020. "This neighborhood is hard hit by COVID-19. Our families work in service industry jobs," said Carlyn Oropez, director of operations at the facility. "Most of the people here have had reduction in hours, reduction in pay, or have lost their jobs. They are coming here for help with basic needs." (AP Photo/Jae C. Hong)
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

By Lauran Neergaard And Matthew Perrone Dec. 18, 2020 12:22 PM EST

Dry ice is poured into a box containing the Pfizer-BioNTech COVID-19 vaccine as it is prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Sunday, Dec. 13, 2020. (AP Photo/Morry Gash, Pool)
The Latest: COVID-19 vaccine begins arriving in Canada

The Associated Press Dec. 13, 2020 01:53 AM EST

FILE - In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. Moderna Inc., said Monday, Nov. 16, its COVID-19 vaccine is proving to be highly effective in a major trial. (AP Photo/Ted S. Warren, File)
Volunteers still needed to test variety of COVID-19 vaccines

By Lauran Neergaard Nov. 17, 2020 11:49 AM EST

FILE - This March 16, 2020, file photo shows vials used by pharmacists to prepare syringes used on the first day of a first-stage safety study of the potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. Moderna said Monday, Nov. 16, its COVID-19 vaccine is proving to be highly effective in a major trial. (AP Photo/Ted S. Warren, File)
2nd virus vaccine shows striking success in US tests

By Lauran Neergaard Nov. 16, 2020 07:00 AM EST

President Donald Trump arrives at his campaign rally at Opa-Locka Executive Airport, late Sunday, Nov. 1, 2020, in Opa-Locka, Fla. (AP Photo/Jim Rassol)
Trump threatens to fire Fauci in rift with disease expert

By Zeke Miller Nov. 02, 2020 01:17 AM EST

This December 2016 photo provided by the family shows, from left, Lu Wang, Ming Wang and Anne Peterson. Ming Wang, 71, was sickened in March 2020 on a cruise from Australia with his wife, a break after decades of running the family’s Chinese restaurant in Papillion, Neb. In the 74 days he was hospitalized, doctors desperately tried various experimental approaches, including enrolling him in a study of an antiviral drug that ultimately showed promise. Ming died on June 8. “It was just touch and go. Everything they wanted to try we said yes, do it,” said his daughter, Anne Peterson. “We would give anything to have him back, but if what we and he went through would help future patients, that’s what we want.” (Anne Peterson via AP)
Nearly 1M who died of COVID-19 also illuminated treatment

By Marilynn Marchione Sep. 27, 2020 10:36 AM EDT

Juan Casuso, right, research coordinator from the University of Miami Miller School of Medicine, speaks with volunteer Julio Li during the intake process for Li to participate in testing for the National Institutes of Health-funded Moderna COVID-19 vaccine, Wednesday, Sept. 2, 2020 in Miami. Miami is one of 89 cities around the U.S., that's testing the Moderna COVID-19 vaccine. Study participants do not know if they're getting the vaccine or a placebo. (AP Photo/Taimy Alvarez)
Push is underway to test COVID-19 vaccines in diverse groups

By Lauran Neergaard And Federica Narancio Sep. 18, 2020 11:41 AM EDT

Members of the Shanksville Volunteer Fire Department present a flag to Democratic presidential candidate and former Vice President Joe Biden and his wife Jill Biden during a visit in Shanksville, Pa., Friday, Sept. 11, 2020. The Bidens stopped by after visiting the nearby Flight 93 National Memorial to commemorate the 19th anniversary of the Sept. 11 terrorist attacks. (AP Photo/Patrick Semansky)
AP FACT CHECK: Trump vs. Trump on virus; Biden missteps

By Hope Yen And Calvin Woodward Sep. 12, 2020 08:28 AM EDT

Dr. Francis Collins, Director of the National Institutes of Health, gives an opening statement during a Senate Health, Education, Labor and Pensions Committee hearing to discuss vaccines and protecting public health during the coronavirus pandemic on Capitol Hill, Wednesday, Sept. 9, 2020, in Washington. (Greg Nash/Pool via AP)
Vaccine by Nov. 3? Halted study explains just how unlikely

By Lauran Neergaard Sep. 09, 2020 10:21 AM EDT

FILE - This July 18, 2020, file photo, shows the AstraZeneca offices in Cambridge, England. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. The company said the study will involve up to 30,000 adults from various racial, ethnic and geographic groups. (AP Photo/Alastair Grant, File)
Third virus vaccine reaches major hurdle: final US testing

By Lauran Neergaard And Carla K. Johnson Sep. 01, 2020 11:57 AM EDT

Committee Chairman Rep. James Clyburn, D-S.C., points to a chart during a House Oversight and Reform Subcommittee, on the Trump administrations response the the Coronavirus crisis, Tuesday, Sept. 1, 2020, on Capitol Hill in Washington. (Graeme Jennings/Pool via AP)
The Latest: Australian hot spot extends state of emergency

By The Associated Press Sep. 01, 2020 01:52 AM EDT

FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. (AP Photo/Hans Pennink)
Debate begins for who's first in line for COVID-19 vaccine

By Lauran Neergaard Aug. 02, 2020 07:05 AM EDT